NEUROCRINE BIOSCIENCES INC's ticker is and the CUSIP is 64125C909. A total of 3 filers reported holding NEUROCRINE BIOSCIENCES INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $4,462,000 | -27.4% | 1,153 | -5.0% | 0.26% | +13.0% |
| Q3 2016 | $6,148,000 | +66.4% | 1,214 | +49.3% | 0.23% | +19.2% |
| Q2 2016 | $3,695,000 | -48.9% | 813 | -36.3% | 0.19% | -51.4% |
| Q4 2015 | $7,224,000 | +29.4% | 1,277 | -9.0% | 0.40% | +72.6% |
| Q3 2015 | $5,583,000 | -15.5% | 1,403 | +1.4% | 0.23% | -4.6% |
| Q2 2015 | $6,605,000 | +29.1% | 1,383 | +7.4% | 0.24% | +13.1% |
| Q1 2015 | $5,115,000 | +43.7% | 1,288 | -19.1% | 0.21% | +90.2% |
| Q4 2014 | $3,559,000 | +35.6% | 1,593 | -4.9% | 0.11% | +10.9% |
| Q3 2014 | $2,625,000 | +33.3% | 1,675 | +26.2% | 0.10% | +20.2% |
| Q2 2014 | $1,969,000 | -6.4% | 1,327 | +1.5% | 0.08% | -28.8% |
| Q1 2014 | $2,104,000 | +72.3% | 1,307 | 0.0% | 0.12% | +51.3% |
| Q4 2013 | $1,221,000 | -76.4% | 1,307 | -66.1% | 0.08% | -77.4% |
| Q2 2013 | $5,166,000 | – | 3,861 | – | 0.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 1,307 | $1,221,000 | 0.08% |
| GROUP ONE TRADING, L.P. | 35,300 | $330,000 | 0.01% |
| Citadel Advisors | 18,000 | $168,000 | 0.00% |